It combines two unrelated active ingredients, clothianidin and deltamethrin, providing dual modes of action that help control mosquito populations, including pyrethroid-resistant strains. As the first IRS product to combine a neonicotinoid and a pyrethroid in a single formulation, Fludora® Fusion was specifically developed to support insecticide resistance management while maintaining high levels of efficacy. Residual activity of up to 12 months has been observed depending on surface type, mosquito strain and environmental conditions

Dual mode of action

• Combines two unrelated insecticide classes for enhanced efficacy and resistance management.

Effective against resistant mosquitoes

• Proven effective against multiple mosquito strains resistant to pyrethroids, carbamates and organophosphates.

Fast knockdown

• Deltamethrin delivers rapid mosquito knockdown, improving immediate control and user confidence.

Long residual protection

• Provides extended residual activity, reducing retreatment frequency and improving programme efficiency. Residual control for up to 12 months has been observed under certain conditions.

Resistance management tool

• The combination of two unrelated modes of action helps delay resistance development and supports long-term vector control strategies.

Cost-efficient coverage

• Low-volume water-soluble sachets provide convenient handling, transport and storage for large-scale vector control programmes.

Target pests

• Malaria vectors (Anopheles spp.)
• Aedes mosquitoes
• Other public health mosquito species according to local registration.

Application areas

• Residential buildings
• Public buildings
• Community health programmes
• Vector control campaigns
• Government mosquito control initiatives
• Rural and urban housing environments

Active ingredients

• Clothianidin 500 g/kg (50%)
• Deltamethrin 62.5 g/kg (6.25%)

Authorization number

• Saudi Arabia: PHPR-2023-P-0041